Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Jane Gallagher

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Annals of the New York Academy of Sciences|November 11, 2010
Bone physiology and therapeutics in chronic critical illnessMichael A Via, Emily Jane Gallagher, Jeffrey I Mechanick
Frontiers in Endocrinology|July 17, 2023
Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitorDouglas Tremblay, Mikaela Dougherty, John Mascarenhas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2016
Type 2 Diabetes Mellitus and Cancer: The Role of PharmacotherapyGadi Shlomai, Brian Neel, Derek LeRoith, et al.
Endocrine-Related Cancer|October 18, 2022
Unregulated LDL cholesterol uptake is detrimental to breast cancer cellsTiffany Scully, Abora Ettela, Nathan Kase, et al.
Current Problems in Cancer. Case Reports|May 1, 2023
Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomyAlaina J Kessler, Rima Patel, Emily Jane Gallagher, et al.
Endocrine-Related Cancer|July 21, 2016
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic miceZara Zelenko, Emily Jane Gallagher, Irini Markella Antoniou, et al.
Annals of Epidemiology|July 5, 2020
Where you live can impact your cancer risk: a look at multiple myeloma in New York CityGeetanjali R Kamath, Anne S Renteria, Sundar Jagannath, et al.
Diabetes/Metabolism Research and Reviews|September 12, 2013
The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetesEmily Jane Gallagher, Hui Sun, Caroline Kornhauser, et al.
Frontiers in Oncology|July 1, 2015
Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate CancerJeffrey Shevach, Emily Jane Gallagher, Teena Kochukoshy, et al.
Endocrine-Related Cancer|August 24, 2017
OP449 inhibits breast cancer growth without adverse metabolic effectsGadi Shlomai, Zara Zelenko, Irini Markella Antoniou, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Annals of the New York Academy of Sciences|November 11, 2010
Bone physiology and therapeutics in chronic critical illnessMichael A Via, Emily Jane Gallagher, Jeffrey I Mechanick
Frontiers in Endocrinology|July 17, 2023
Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitorDouglas Tremblay, Mikaela Dougherty, John Mascarenhas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2016
Type 2 Diabetes Mellitus and Cancer: The Role of PharmacotherapyGadi Shlomai, Brian Neel, Derek LeRoith, et al.
Endocrine-Related Cancer|October 18, 2022
Unregulated LDL cholesterol uptake is detrimental to breast cancer cellsTiffany Scully, Abora Ettela, Nathan Kase, et al.
Current Problems in Cancer. Case Reports|May 1, 2023
Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomyAlaina J Kessler, Rima Patel, Emily Jane Gallagher, et al.
Endocrine-Related Cancer|July 21, 2016
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic miceZara Zelenko, Emily Jane Gallagher, Irini Markella Antoniou, et al.
Annals of Epidemiology|July 5, 2020
Where you live can impact your cancer risk: a look at multiple myeloma in New York CityGeetanjali R Kamath, Anne S Renteria, Sundar Jagannath, et al.
Diabetes/Metabolism Research and Reviews|September 12, 2013
The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetesEmily Jane Gallagher, Hui Sun, Caroline Kornhauser, et al.
Frontiers in Oncology|July 1, 2015
Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate CancerJeffrey Shevach, Emily Jane Gallagher, Teena Kochukoshy, et al.
Endocrine-Related Cancer|August 24, 2017
OP449 inhibits breast cancer growth without adverse metabolic effectsGadi Shlomai, Zara Zelenko, Irini Markella Antoniou, et al.
Pageof 3